By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider activity at Editas Medicine, Inc. has been all selling for a year now: about $107,000 from three sellers, and zero buyers with their own money.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. 215 investment managers listed EDIT in their latest 13F filings (Q2 2026); more funds bought than sold.
Are insiders buying or selling EDIT stock?
In the last 12 months Editas Medicine, Inc. insiders made open-market purchases worth about $0 and sales worth about $107,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in EDIT?
The most recent open-market insider trade in EDIT was filed on 2026-09-04.
How many institutions own EDIT?
215 investment managers reported holding EDIT in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded EDIT?
No congressional trades in EDIT were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).